Daphnetin inhibits the proliferation, clonal formation, migration, and invasion of lung adenocarcinoma A549 cells by inhibiting the activation of the MAPK, NF-κB, and STAT3 signaling pathways. The gene discussed is NFKB1; the disease is lung adenocarcinoma.